Fibrinogen as a promising material for various biomedical applications

Jae Yeon Joo; Md. Lutful Amin; Thanavel Rajangam; Seong Soo A. An

doi:10.1007/s13273-015-0001-y

Molecular & Cellular Toxicology

March 2015, Volume 11, Issue 1, pp 1–9

Fibrinogen as a promising material for various biomedical applications

Authors
Authors and affiliations

Jae Yeon Joo
Md. Lutful Amin
Thanavel Rajangam
Seong Soo A. AnEmail author

Review Paper

First Online:: 02 April 2015

Received:: 22 October 2014
Accepted:: 29 December 2014

DOI: 10.1007/s13273-015-0001-y

Cite this article as:: Joo, J.Y., Amin, M.L., Rajangam, T. et al. Mol. Cell. Toxicol. (2015) 11: 1. doi:10.1007/s13273-015-0001-y

1 Citations
252 Downloads

Abstract

As demands for innovative drug carriers and transplantable organs increase, many researchers have developed diverse drug carriers and scaffolds using various materials. However, several candidate materials have shown systemic toxicity, making them unsuitable for clinical use. Fibrinogen (Fbg), a natural polymer, could be a promising material for applications in biomedical engineering owing to its biocompatibility and biodegradability, as reported in numerous studies. Moreover, autologous Fbg is abundant in blood and can be easily extracted, presenting Fbg as an excellent biomaterial for biomedical applications due to minimal immunological rejection. In addition, the biocompatibility of other materials could be improved by combining them with Fbg. Over the next few years, Fbg could be widely used in various biomedical and clinical fields. Here, we discuss the characteristics of Fbg and fabricating methods for Fbg scaffolds in various biomedical applications. The future prospects of Fbg as an applicable biomaterial, especially in organ fabrication by the cutting-edge 3D bioprinting technology, are also presented.

Keywords

Fibrinogen Drug carrier Arginine-glycine-aspartate peptide Tissue engineering Biocompatible material Autologous 3D bio-printing Microspheres Microtubes

References

1.
Sharma, A. & Jain, C. P. Solid dispersion: A promising technique to enhance solubility of poorly water soluble drug. Int J Drug Delivery 3:149–170 (2011).Google Scholar
2.
Bhunchu, S. & Rojsitthisak, P. Biopolymeric alginatechitosan nanoparticles as drug delivery carriers for cancer therapy. Die Pharmazie 69:563–570 (2014).PubMedGoogle Scholar
3.
Allen, T. M. & Cullis, P. R. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Delivery Rev 65:36–48 (2013).CrossRefGoogle Scholar
4.
Grossman, J. H. & McNeil, S. E. Nanotechnology in Cancer Medicine. Phys Today 65:38 (2012).CrossRefGoogle Scholar
5.
Beenken-Rothkopf, L. N. et al. The incorporation of extracellular matrix proteins in protein polymer hydrogels to improve encapsulated beta-cell function. Ann Clin Lab Sci 43:111–121 (2013).PubMedGoogle Scholar
6.
Choi, J. H. et al. Fabrication of HepG2 cell laden collagen microspheres using inkjet printing. J Korean Soc Precis Eng 31:743–747 (2014).CrossRefGoogle Scholar
7.
Chan, B. P. et al. Mesenchymal stem cell-encapsulated collagen microspheres for bone tissue engineering. Tissue Eng Part C 16:225–235 (2010).CrossRefGoogle Scholar
8.
Kopecek, J., Kopeckova, P., Minko, T. & Lu, Z. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur J Pharm Biopharm 50: 61–81 (2000).CrossRefPubMedGoogle Scholar
9.
Drobnik, J., Saudek, V., Vlasak, J. & Kalal, J. Polyaspartamide-a potential drug carrier. J Polym Sci: Polym Symp 66:65–74 (1979).Google Scholar
10.
Cai, W., Gao, T., Hong, H. & Sun, J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl 1:17–32 (2008).PubMedCentralPubMedGoogle Scholar
11.
de Jong, W. H. & Borm, P. J. A. Drug delivery and nanoparticles: Applications and hazards. Int J Nanomed 3:133–149 (2008).CrossRefGoogle Scholar
12.
Adhirajan, N., Shanmugasundaram, N. & Babu, M. Gelatin microspheres cross-linked with EDC as a drug delivery system for doxycyline: development and characterization. J Microencapsulation 24:647–659(2007).CrossRefPubMedGoogle Scholar
13.
Rathod, S. & Deshpande, S. G. Albumin microspheres as an ocular delivery system for pilocarpine nitrate. Indian J Pharm Sci 70:193–197 (2008).CrossRefPubMedCentralPubMedGoogle Scholar
14.
Arangoa, M. A. et al. nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics. Pharm Res 18:1521–1527 (2001).CrossRefPubMedGoogle Scholar
15.
Lazko, J., Popineau, Y. & Legrand, J. Soy glycinin microcapsules by simple coacervation method. Colloids Surf B 37:1–8 (2004).CrossRefGoogle Scholar
16.
Livney, Y. D. Milk proteins as vehicles for bioactives. Curr Opin Colloid Interface Sci 15:73–83 (2010).CrossRefGoogle Scholar
17.
Rajangam, T., Paik, H. J. & An, S. S. A. Development of fibrinogen microspheres as a biodegradable carrier for tissue engineering. BioChip J 5:175–183 (2011).CrossRefGoogle Scholar
18.
Stec, J. J. et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 102: 1634–1638 (2000).CrossRefPubMedGoogle Scholar
19.
Mosesson, M. W., Siebenlist, K. R. & Meh, D. A. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936:11–30 (2001).CrossRefPubMedGoogle Scholar
20.
Sporn, L. A., Bunce, L. A. & Francis, C. W. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood 86:1802–1810 (1995).PubMedGoogle Scholar
21.
Hamaguchi, M., Bunce, L. A., Sporn, L. A. & Francis, C. W. Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15–42. Blood 81:2348–2356 (1993).PubMedGoogle Scholar
22.
Skogen, W. F., Senior, R. M., Griffin, G. L. & Wilner, G. D. Fibrinogen-derived peptide B beta 1–42 is a multidomained neutrophil chemoattractant. Blood 71:1475–1479 (1988).PubMedGoogle Scholar
23.
Sahni, A., Odrljin, T. & Francis, C. W. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 273:7554–7559 (1998).CrossRefPubMedGoogle Scholar
24.
Campbell, P. G. et al. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. J Biol Chem 274:30215–30221 (1999).CrossRefPubMedGoogle Scholar
25.
Ruoslahti, E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12:697–715 (1996).CrossRefPubMedGoogle Scholar
26.
Francavilla, C., Maddaluno, L. & Cavallaro, U. The functional role of cell adhesion molecules in tumor angiogenesis. Semin Cancer Biol 19:298–309 (2009).CrossRefPubMedGoogle Scholar
27.
Hallahan, D. et al. Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell 3:63–74 (2003).CrossRefPubMedGoogle Scholar
28.
Zhao, Y. et al. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 67:5821–5830 (2007).CrossRefPubMedGoogle Scholar
29.
Desgrosellier, J. S. et al. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med 15:1163–1169 (2009).CrossRefPubMedCentralPubMedGoogle Scholar
30.
Cooper, C. R., Chay, C. H. & Pienta, K. J. The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia (N. Y., NY, U. S.) 4:191–194 (2002).CrossRefGoogle Scholar
31.
Xu, W. et al. RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating alpha(v)beta(3) expression. Int J Nanomed 7:915–924 (2012).Google Scholar
32.
Ji, S. et al. RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy. Cancer Biol Ther 13:206–215 (2012).CrossRefPubMedGoogle Scholar
33.
Nasongkla, N. et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl 43:6323–6327 (2004).CrossRefPubMedGoogle Scholar
34.
Zhan, C. et al. Cyclic RGD conjugated poly (ethylene glycol)-co-poly (lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Controlled Release 143: 136–142 (2010).CrossRefGoogle Scholar
35.
Borgman, M. P. et al.. Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery. Mol Pharmaceutics 6:1836–1847 (2009).CrossRefGoogle Scholar
36.
Meng, S. et al. Integrin-targeted paclitaxel nanoliposomes for tumor therapy. Med Oncol 28:1180–1187 (2011).CrossRefPubMedGoogle Scholar
37.
Scheffel, U., Rhodes, B. A., Natarajan, T. K. & Wagner, H. N., Jr. Albumin microspheres for study of the reticuloendothelial system. J Nucl Med 13:498–503 (1972).PubMedGoogle Scholar
38.
Miyazaki, S. et al. Fibrinogen microspheres as novel drug delivery systems for antitumor drugs. Chem Pharm Bull 34:1370–1375 (1986).CrossRefPubMedGoogle Scholar
39.
Miyazaki, S. et al. Preparation and evaluation in vitro and in vivo of fibrinogen microspheres containing adriamycin. Chem Pharm Bull 34:3384–3393 (1986).CrossRefPubMedGoogle Scholar
40.
Miyazaki, S. et al. Antitumour effect of fibrinogen microspheres containing doxorubicin on Ehrlich ascites carcinoma. J Pharm Pharmacol 38:618–620 (1986).CrossRefPubMedGoogle Scholar
41.
Rejinold, N. S. et al. Development of novel fibrinogen nanoparticles by two-step co-acervation method. Int J Biol Macromol 47:37–43 (2010).CrossRefPubMedGoogle Scholar
42.
Rejinold, N. S. et al. 5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications. Int J Biol Macromol 48:98–105 (2011).CrossRefPubMedGoogle Scholar
43.
Zhang, S. et al. Size-dependent endocytosis of nanoparticles. Adv Mater 21:419–424 (2009).CrossRefPubMedCentralPubMedGoogle Scholar
44.
Nisisako, T., Torii, T. & Higuchi, T. Droplet formation in a microchannel network. Lab Chip 2:24–26 (2002).CrossRefPubMedGoogle Scholar
45.
Li, X.B. et al. Study on the mechanism of droplet formation in T-junction microchannel. Chem Eng Sci 69: 340–351 (2012).CrossRefGoogle Scholar
46.
Hawiger, J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol 18:111–122 (1987).CrossRefPubMedGoogle Scholar
47.
Spotnitz, W. D. Fibrin sealant: The only approved hemostat, sealant, and adhesive-a Laboratory and clinical perspective. ISRN surgery 2014:1–28 (2014).CrossRefGoogle Scholar
48.
Erdogan, D. & van Gulik, T. M. Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent. J Biomed Mater Res Part B 85:272–278 (2008).CrossRefGoogle Scholar
49.
Zhang, G. et al. PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Eng 12:9–19 (2006).CrossRefPubMedGoogle Scholar
50.
Wnek, G. E., Carr, M. E., Simpson, D. G. & Bowlin, G. L. Electrospinning of nanofiber fibrinogen structures. Nano Lett 3:213–216 (2003).CrossRefGoogle Scholar
51.
Moretz, W. H., Jr., Shea, J. J., Jr., Emmett, J. R. & Shea, J. J., 3rd. A simple autologous fibrinogen glue for otologic surgery. Otolaryngol—Head Neck Surg 95:122–124 (1986).PubMedGoogle Scholar
52.
Dhandayuthapani, B., Yoshida, Y., Maekawa, T. & Kumar, D. S. Polymeric scaffolds in tissue engineering application: A review. Int J Polym Sci 2011:1–19 (2011).CrossRefGoogle Scholar
53.
Peled, E. et al. A novel poly (ethylene glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model. J Biomed Mater Res, Part A 80:874–884 (2007).CrossRefGoogle Scholar
54.
Dejana, E. et al. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest 75:11–18 (1985).CrossRefPubMedCentralPubMedGoogle Scholar
55.
Almany, L. & Seliktar, D. Biosynthetic hydrogel scaf-folds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 26:2467–2477 (2005).CrossRefPubMedGoogle Scholar
56.
He, C. et al. Fabrication of fibrinogen/P (LLA-CL) hybrid nanofibrous scaffold for potential soft tissue engineering applications. J Biomed Mater Res Part A 97: 339–347 (2011).CrossRefGoogle Scholar
57.
Fang, Z. et al. Preparation and biocompatibility of electrospun poly(l-lactide-co-ε-caprolactone)/fibrinogen blended nanofibrous scaffolds. Appl Surf Sci 257: 4133–4138 (2011).CrossRefGoogle Scholar
58.
Percçin, G. K. & Khuri-Yakub, B. T. Piezoelectric droplet ejector for ink-jet printing of fluids and solid particles. Rev Sci Instrum 74:1120 (2003).CrossRefGoogle Scholar
59.
Böhmer, M. R., Steenbakkers, J. A. M. & Chlon, C. Monodisperse polymeric particles prepared by ink-jet printing: Double emulsions, hydrogels and polymer mixtures. Colloids Surf B 79:47–52 (2010).CrossRefGoogle Scholar
60.
Böhmer, M. R. et al. Preparation of monodisperse polymer particles and capsules by ink-jet printing. Colloids Surf A 289:96–104 (2006).CrossRefGoogle Scholar
61.
Fletcher, R. A. et al. Fabrication of polymer microsphere particle standards containing trace explosives using an oil/water emulsion solvent extraction piezoelectric printing process. Talanta 76:949–955 (2008).CrossRefPubMedGoogle Scholar
62.
Radulescu, D., Schwade, N. & Wawro, D. Uniform paclitaxel-loaded biodegradable microspheres manufactured by ink-jet technology. Proc Recent Adv in Drug Delivery Sys 1–5 (2003).Google Scholar
63.
Khatiwala, C. et al. 3d cell bioprinting for regenerative medicine research and therapies. Gene Ther Regul 7: 1230004 (2012).CrossRefGoogle Scholar
64.
Gregor, A., Hošek, J. 3D printing methods of biological materials used in tissue engineering. International Conference MECAHITECH’10, Bucharest, Romania, 23–24 September 2010.Google Scholar
65.
Skardal, A. et al.. Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. Stem Cells Transl Med 1:792–802 (2012).CrossRefPubMedCentralPubMedGoogle Scholar
66.
Reiffel, A. J. et al. High-fidelity tissue engineering of patient-specific auricles for reconstruction of pediatric microtia and other auricular deformities. PloS One 8: e56506 (2013).CrossRefPubMedCentralPubMedGoogle Scholar
67.
Atala, A. et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367:1241–1246 (2006).CrossRefPubMedGoogle Scholar
68.
Fielding, G. & Bose, S. SiO₂ and ZnO dopants in threedimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo. Acta Biomater 9:9137–9148 (2013).CrossRefPubMedGoogle Scholar
69.
Zopf, D. A. et al. Bioresorbable airway splint created with a three-dimensional printer. N Engl J Med 368:2043–2045 (2013).CrossRefPubMedGoogle Scholar
70.
Nakamura, M. et al. Computer-assisted biofabrication. Symposium on VLSI Technology Digest of Technical Papers, Kyoto, Japan, June 2011.Google Scholar
71.
Mironov, V. et al. Organ printing: computer-aided jetbased 3D tissue engineering. Trends Biotechnol 21:157–161 (2003).CrossRefPubMedGoogle Scholar
72.
Mironov, V. et al. Organ printing: tissue spheroids as building blocks. Biomaterials 30:2164–2174 (2009).CrossRefPubMedCentralPubMedGoogle Scholar
73.
Cui, X. & Boland, T. Human microvasculature fabrication using thermal inkjet printing technology. Biomaterials 30:6221–6227 (2009).CrossRefPubMedGoogle Scholar

Fibrinogen as a promising material for various biomedical applications

Abstract

Keywords

Copyright information

Authors and Affiliations

Personalised recommendations

Cookies